Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in ANRO — Alto Neuroscience, Inc.

CIK 1603466 STAMFORD, CT
Back to ANRO Full portfolio

Position in ANRO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$13,272,850
+$1,963,455 QoQ
Shares Held
502,950
-0.0% QoQ
Ownership
1.28%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#18
of 114 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ANRO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. ANRO ranks #44 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 4,473,478 $158,316,386
2 CYTK
Cytokinetics Inc
 1,587,712 $135,257,185
3 BBIO
BridgeBio Pharma, Inc.
 1,525,782 $113,640,243
4 AXSM
Axsome Therapeutics, Inc.
 416,516 $101,950,621
5 LEGN
Legend Biotech Corp
 3,076,124 $88,838,461
6 MDGL
Madrigal Pharmaceuticals, Inc.
 137,029 $73,577,721
7 CELC
Celcuity Inc.
 650,916 $68,098,831
8 ACAD
Acadia Pharmaceuticals Inc
 2,433,168 $61,559,150

All Filings in ANRO

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,272,850 502,950
2026-03-31 $11,309,395 503,087
2025-12-31 $28,603,781 1,606,954
2025-09-30 $5,356,396 1,332,437
2025-06-30 $2,925,461 1,329,755
2025-03-31 $2,678,514 1,240,053
2024-12-31 $7,157,807 1,692,153
2024-09-30 $11,184,796 977,692
2024-06-30 $11,224,895 1,050,037
2024-03-31 $17,268,750 1,125,000